(Q40082680)

17 September 2017

title

Effect of betulinic acid on anticancer drug-resistant colon cancer cells (English)

1 reference

17 September 2017

0 references

1 reference

Gwon-Ryul Jung

1

1 reference

17 September 2017

Kyung-Jong Kim

2

1 reference

17 September 2017

Cheol-Hee Choi

3

1 reference

17 September 2017

Tae-Beum Lee

4

1 reference

17 September 2017

Song Iy Han

5

1 reference

17 September 2017

Hyo-Kyung Han

6

1 reference

17 September 2017

Sung-Chul Lim

7

1 reference

17 September 2017

publication date

1 October 2007

1 reference

Basic and Clinical Pharmacology and Toxicology

17 September 2017

published in

1 reference

17 September 2017

volume

101

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

277-285

1 reference

describes a project that uses

17 September 2017

0 references

0 references

0 references

Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

The changing face of chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Cellular stress response and apoptosis in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Mechanisms of drug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-Fluorouracil Refractory Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Sensitization for anticancer drug-induced apoptosis by betulinic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00115.X

10.1111/J.1742-7843.2007.00115.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference